Consultation on the Cost-Effectiveness Methodology for Vaccination Programmes & Procurement (CEMIPP) Report

Closed 28 Jun 2018

Opened 26 Feb 2018


The Joint Committee on Vaccination and Immunisation (JCVI), is the independent expert committee that advises ministers on the introduction of new, and changes to existing, vaccination programmes in the UK. They asked that the methodology they use to appraise the cost–effectiveness of vaccination programmes be reviewed to see if it should differ from those used for appraising other health-related activities that use public resources.

The Cost-Effectiveness Methodology for Immunisation Programmes & Procurement (CEMIPP) group was set up as a result and reported in July 2016. A further group, the Department of Health & Social Care’s Appraisal Alignment Working Group (AAWG), set up in 2014 to consider the divergent approaches to cost-effectiveness analysis across the health and care system in England, was asked to provide a view before the CEMIPP report was published. This was received at the end of January 2018. The CEMIPP report and the AAWG’s conclusions have now been published.

Update to the consultation

On 17 May 2018 we extended the closing date for the consultation by 6 weeks.

Following feedback, we have published additional information (including the potential effect on vaccination programmes) to help stakeholders better understand the main recommendations in the CEMIPP report. 
To give you more time to consider this additional information, the closing date of the consultation will now be 28 June 2018
After the introductory questions you will have the option to complete the entire survey or provide general comments on any aspect of the CEMIPP report. 
Before you start to complete the on-line form, you can request a copy of the survey questions by sending an email to:    
If you have already responded and would like to provide additional information as a result of the new information provided you can submit this to:
Please include the reference number you were given for the initial response so that we can link the responses.


Why We Are Consulting

There have been a number of calls in England to consult on the CEMIPP report from charities, the pharmaceutical industry and parliamentary committees. In view of this, we are consulting on the recommendations in the CEMIPP report. It is a complex and technical report. This consultation is therefore primarily aimed at specialists with an interest in health economics although responses from other interested parties are welcome. The consultation seeks views and further evidence to inform the Government’s decision on this report.


  • Charities
  • Clinicians
  • Commissioners
  • Directors of Public Health
  • Providers of NHS clinical services
  • NHS Commissioning Board
  • Clinical Commissioning Groups
  • clinical staff
  • patient groups and patient advocates
  • Regulatory body
  • Academic/ Professional institution
  • Royal Colleges
  • Local authority
  • Suppliers


  • Public health
  • Immunisation
  • Funding